The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help.
Open accessAbstract
The activation requirements for the generation of CD8+ cytotoxic T cells (CTL) are poorly understood. Here we demonstrate that in the absence of exogenous help, a CD28-B7 interaction is necessary and sufficient for generation of class I major histocompatibility complex-specific CTL. Costimulation is required only during the inductive phase of the response, and not during the effector phase. Transfection of the CD28 counter receptor, B7, into nonstimulatory P815 cells confers the ability to elicit P815-specific CTL, and this response can be inhibited by anti-CD28 Fab or by the chimeric B7-binding protein CTLA4Ig. Anti-CD28 monoclonal antibody (mAb) can provide a costimulatory signal to CD8+ T cells when the costimulatory capacity of splenic stimulators is destroyed by chemical fixation. CD28-mediated signaling provokes the release of interleukin 2 (IL-2) from the CD8+ CTL precursors, as anti-CD28 mAb could be substituted for by the addition of IL-2, and an anti-IL-2 mAb can block the generation of anti-CD28-induced CTL. CD4+ cells are not involved in the costimulatory response in the systems examined. We conclude that CD8+ T cell activation requires two signals: an antigen-specific signal mediated by the T cell receptor, and an additional antigen nonspecific signal provided via a CD28-B7 interaction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CTLA-4 is a second receptor for the B cell activation antigen B7.
Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L. S., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.561 · Cited by 1,685
Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H., & Allison, J. P. (1992) · Nature · doi:10.1038/356607a0 · Cited by 1,559
Self-citationJenkins, M. K., & Schwartz, R. H. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.2.302 · Cited by 1,170
Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells
Townsend, S. E., & Allison, J. P. (1993) · Science · doi:10.1126/science.7678351 · Cited by 1,136
Self-citationLinsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.721 · Cited by 1,127
Chen, L., Ashe, S., Brady, W. A., Hellström, I., Hellström, K. E., Ledbetter, J. A., McGowan, P., & Linsley, P. S. (1992) · Cell · doi:10.1016/s0092-8674(05)80059-5 · Cited by 1,050
T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.
Linsley, P. S., Clark, E. A., & Ledbetter, J. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5031 · Cited by 747
Rahemtulla, A., Fung-Leung, W. P., Schilham, M. W., Kündig, T. M., Sambhara, S. R., Narendran, A., Arabian, A., Wakeham, A., Paige, C. J., Zinkernagel, R. M., et al. (1991) · Nature · doi:10.1038/353180a0 · Cited by 684
CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.
Thompson, C. B., Lindsten, T., Ledbetter, J. A., Kunkel, S. L., Young, H. A., Emerson, S. G., Leiden, J. M., & June, C. H. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1333 · Cited by 659
Helper activity is required for the in vivo generation of cytotoxic T lymphocytes
Keene, J.-A., & Forman, J. (1982) · The Journal of Experimental Medicine · doi:10.1084/jem.155.3.768 · Cited by 500
The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.
Koulova, L., Clark, E. A., Shu, G., & Dupont, B. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.759 · Cited by 321
Azuma, M., Cayabyab, M., Buck, D., Phillips, J. H., & Lanier, L. L. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.2.353 · Cited by 318
Identification and distribution of the costimulatory receptor CD28 in the mouse
Gross, J. A., Callas, E., & Allison, J. P. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.2.380 · Cited by 309
Self-citationFunctional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations.
Larsen, C. P., Ritchie, S. C., Pearson, T. C., Linsley, P. S., & Lowry, R. P. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.4.1215 · Cited by 302
Young, J. W., Koulova, L., Soergel, S. A., Clark, E. A., Steinman, R. M., & Dupont, B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115840 · Cited by 265
Jenkins, M. K., Ashwell, J. D., & Schwartz, R. H. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.10.3324 · Cited by 258
Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells.
Inaba, K., Young, J. W., & Steinman, R. M. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.1.182 · Cited by 240
Razi-Wolf, Z., Freeman, G. J., Galvin, F., Benacerraf, B., Nadler, L., & Reiser, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.4210 · Cited by 210
Wong, G. H. W., Clark‐Lewis, I., Harris, A. W., & Schrader, J. W. (1984) · European Journal of Immunology · doi:10.1002/eji.1830140110 · Cited by 190
Otten, G. R., & Germain, R. N. (1991) · Science · doi:10.1126/science.1900952 · Cited by 189
Role of Lymphokine and Antigen in the Control of Specific T Cell Responses
Lafferty, K. J., Andrus, L., & Prowse, S. J. (1980) · Immunological Reviews · doi:10.1111/j.1600-065x.1980.tb00325.x · Cited by 146
Sprent, J., & Schaefer, M. L. (1985) · The Journal of Experimental Medicine · doi:10.1084/jem.162.6.2068 · Cited by 134
Reiser, H., Freeman, G. J., Razi-Wolf, Z., Gimmi, C. D., D, B. B. M., & Nadler, L. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.271 · Cited by 128
Mizuochi, T., Ono, S., Malek, T. R., & Singer, A. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.163.3.603 · Cited by 90
Priming of influenza virus-specific cytotoxic T lymphocytes vivo by short synthetic peptides
Gao, X. M., Zheng, B. Q., Liew, F. Y., Brett, S. J., & Tite, J. P. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.10.3268 · Cited by 87
McCormack, J. M., Sun, D., & Walker, W. S. G. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.2.421 · Cited by 25
Cited by
Reciprocal regulation of polarized cytokine production by effector B and T cells
Harris, D. P., Haynes, L., Sayles, P. C., Duso, D. K., Eaton, S. M., Lepak, N. M., Johnson, L. L., Swain, S. L., & Lund, F. E. (2000) · Nature Immunology · doi:10.1038/82717 · Cited by 839
Inaba, K., Witmer-Pack, M., Inaba, M., Hathcock, K. S., Sakuta, H., Azuma, M., Yagita, H., Okumura, K., Linsley, P. S., Ikehara, S., et al. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1849 · Cited by 592
Finney, H. M., Lawson, A. D. G., Bebbington, C. R., & Weir, A. N. C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2791 · Cited by 546
Chambers, C. A., Sullivan, T. J., & Allison, J. P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80406-9 · Cited by 411
Self-citationPivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity
Guinan, E., Gribben, J., Boussiotis, V., Freeman, G., & Nadler, L. (1994) · Blood · doi:10.1182/blood.v84.10.3261.3261 · Cited by 358
Metadata
- Authors
- Harding, F. A., & Allison, J. P.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1993-06-01
- Volume
- 177
- Issue
- 6
- Pages
- 1791-1796
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2143188779
- Cited by
- 265
- References
- 26
- FWCI
- 10.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.